BioLineRx Ltd. (BLRX) stock
BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)
Close on Nov 17, 2026Market cap $4.87MP/E –Yield –
BioLineRx cash
Cash and short-term investments held at the end of each period.
BioLineRx's cash was $4.63M at Jun 30, 2026. For fiscal 2025 it was $3.25M, down 68.9% from the year before. Over ten years it grew -5.2% a year on average. The highest annual figure on record is $16.83M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.25M | -68.9% |
| FY2024 | Dec 31, 2024 | $10.44M | +145.3% |
| FY2023 | Dec 31, 2023 | $4.26M | -59.8% |
| FY2022 | Dec 31, 2022 | $10.59M | -18.5% |
| FY2021 | Dec 31, 2021 | $12.99M | -22.8% |
| FY2020 | Dec 31, 2020 | $16.83M | +217.7% |
| FY2019 | Dec 31, 2019 | $5.30M | +55.6% |
| FY2018 | Dec 31, 2018 | $3.40M | -33.4% |
| FY2017 | Dec 31, 2017 | $5.11M | +107.0% |
| FY2016 | Dec 31, 2016 | $2.47M | -55.5% |
| FY2015 | Dec 31, 2015 | $5.54M | -4.2% |
| FY2014 | Dec 31, 2014 | $5.79M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $4.63M | -51.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.25M | -23.6% |
| Q2 FY2025 | Jun 30, 2025 | $7.19M | -28.8% |
| Q4 FY2024 | Dec 31, 2024 | $10.44M | -1.4% |
| Q2 FY2024 | Jun 30, 2024 | $9.62M | -31.3% |
| Q4 FY2023 | Dec 31, 2023 | $4.26M | -67.2% |
| Q2 FY2023 | Jun 30, 2023 | $10.10M | -42.2% |
| Q4 FY2022 | Dec 31, 2022 | $10.59M | -37.1% |
| Q2 FY2022 | Jun 30, 2022 | $14.00M | +153.5% |
| Q4 FY2021 | Dec 31, 2021 | $12.99M | +145.2% |
| Q2 FY2021 | Jun 30, 2021 | $17.48M | +251.6% |
| Q4 FY2020 | Dec 31, 2020 | $16.83M | +394.4% |
| Q2 FY2020 | Jun 30, 2020 | $5.52M | -4.6% |
| Q4 FY2019 | Dec 31, 2019 | $5.30M | +3.7% |
| Q2 FY2019 | Jun 30, 2019 | $4.97M | -28.4% |
| Q4 FY2018 | Dec 31, 2018 | $3.40M | +37.9% |
| Q2 FY2018 | Jun 30, 2018 | $5.79M | +4.4% |
| Q4 FY2017 | Dec 31, 2017 | $5.11M | -11.7% |
| Q2 FY2017 | Jun 30, 2017 | $6.95M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.47M | – |
| Q4 FY2015 | Dec 31, 2015 | $5.54M | – |
| Q4 FY2014 | Dec 31, 2014 | $5.79M | – |
See a number that looks wrong?